Article
Organometallics, Vol. 29, No. 4, 2010 787
was extracted with toluene. After filtration of the toluene solu-
tion through Celite and evaporation to dryness, 20 was obtained
as a yellow-orange powder (128 mg, 69%). 1H NMR (C6D6,
400 MHz): δ 7.84-7.35 (series of m, 10H, Har), 6.87 (s, 0.9H,
N(CH)2N of one isomer), 6.86 (s, 1.1H, N(CH)2N of other
isomer), 3.63-3.00 (series of m, 4H, CH(CH3)2), 1.55-1.37
(series of d, 24H, CH(CH3)2) ppm. 13C{1H} NMR (125 MHz,
C6D6): δ 221.6, 221.3 (N-C-N), 147.4, 147.3, 143.1, 143.0, 135.9,
135.8, 132.7, 132.3, 131.9, 131.8, 128.6, 128.3, 128.1, 127.9, 126.1,
125.3, 123.3, 123.2, 122.4, 122.3, 120.7, 120.0 (Car), 35.2, 34.8, 29.0,
28.9 (CH(CH3)2), 24.4, 24.3, 24.25, 24.2, 24.1, 23.9, 23.7, 23.6
(Ar-CH(CH3)2) ppm.
started at this point) and introduced to the spectrometer, and
conversions were obtained by 1H NMR.
4.3.3. RCM of Allylmethallyl Tosylamide (11) and Diethyl
Allylmethallylmalonate (12). 4.3.3.1. Catalyst Loading of 0.5
mol %. To obtain the required catalyst amount, a solution of the
appropriate ruthenium complex (4 ꢀ 10-3 mmol) in 2 mL of
CH2Cl2 was prepared. A 200 μL portion of this solution was
transferred to a NMR tube and evaporated to dryness, and the
residue was dried for 1 h under vacuum. The tube was then
closed with a screw-cap septum top. Separately, in a small vial,
substrates 11 and 12 (0.08 mmol, 21.2 and 20.3 mg, respectively)
were dissolved in 0.8 mL (0.1 M) of CD2Cl2 and then transferred
via syringe to the respective NMR tubes containing the catalyst.
The tube was vigorously stirred for a few seconds (the reaction
time was started at this point) and introduced to the spectro-
meter, and conversions were obtained by 1H NMR.
4.4. Preparative Metathesis Reactions. 4.4.1. General Re-
marks. A Schlenk flask, under argon, was charged with the sub-
strate (0.5 mmol) and dry dichloromethane (5 mL, C=0.1 M),
and then the precatalyst (0.005 mmol) was added. The progress
of the reaction was monitored by TLC. The solvent was removed
under vacuum, and the crude residue was purified by flash
column chromatography to yield the pure product. Most sub-
strates and products have been previously described.3b,24,37-40
Characterization of new catalytic products is as follows.
4.4.2. (E)-6-Hydroxyhex-4-enyl benzoate (Table 3, Entry 4).
Colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.98-7.94 (m, 2H,
HPh), 7.50-7.44 (m, 1H, HPh), 7.38-7.32 (m, 2H, HPh), 5.64-5.60
(m, 2H, CHdCH), 4.24 (t, J(H,H) = 6.5 Hz, 2H, O-CH2), 4.00
(d, J(H,H) = 4.3 Hz, 2H, CH2-OH), 2.16-2.10 (m, 2H, CH2-
CHdCH), 1.97 (s bd, 1H, OH), 1.78 (quint, J(H,H) = 7.0 Hz, 2H,
CH2-CH2-CH2) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ
167.1 (C), 133.3 (CH), 131.7 (CH), 130.7 (C), 130.5 (CH), 129.9
(CH), 128.8 (CH), 64.7 (CH2), 58.7 (CH2), 29.0 (CH2), 28.5 (CH2)
ppm. HRMS (ESI): m/z calcd for C13H16O3Na 243.0997 [M þ
Na]þ, found 243.0991.
4.4.3. (E)-N-(4-Oxopent-2-enyl)benzamide (Table 3, Entry 6).
Colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.74-7.72 (m, 2H,
HPh), 7.48-7.43 (m, 1H, HPh), 7.39-7.35 (m, 2H, HPh), 6.74 (td,
J(H,H) = 16.1 and 5.1 Hz, 1H, CHdCH-CO), 6.57 (s br, 1H,
NH), 6.11 (td, J(H,H) = 16.1 and 1.7 Hz, 1H, CO-CHdCH),
4.19 (dt, J(H,H) = 6.0 and 0.9 Hz, 2H, CH2-NH), 2.18 (s, 2H,
CH3) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ 198.6 (C), 167.9
(C), 143.3 (CH), 134.2 (C), 132.3 (CH), 131.4 (CH), 129.1 (CH),
128.9 (CH), 127.4 (CH), 41.2 (CH2), 27.6 (CH3) ppm. HRMS
4.2.8. [RuCl2{(2,7)-IPrNap}(dCHPh)(PCy3)] (21; ca. 1:1
Syn/Anti). In 20 mL of toluene, a mixture of the free carbene
(2,7)-IPrNap (20; 128 mg, 0.262 mmol) and [RuCl2(dCHPh)-
(PCy3)2] (GI; 166 mg, 0.201 mmol) was stirred at room tempera-
ture. After 24 h, complete consumption of [RuCl2(dCHPh)-
(PCy3)2] was observed by 31P NMR spectroscopy; the solution
was evaporated to dryness and dried overnight under vacuum.
The dark red residue was washed with 10 mL of methanol and
dissolved in a minimum of CH2Cl2. Diffusion of MeOH into this
concentrated solution gave 21 as dark red crystals suitable for
1
X-ray structure analysis. Yield: 100 mg (48%). H NMR (400
MHz, CD2Cl2, 27 °C): δ 19.43 (s, 1H, RudCH-Ph), 8.03-6.61
(m, 17H, Harom and N(CH)2N), 3.98-3.01 (series of m and sept,
4H, ArCH(CH3)2), 2.03-0.55 (series of m, 57H, ArCH(CH3)2
and P(C6H11)3) ppm. 13C{1H} NMR (125 MHz, CD2Cl2): δ
192.2, 191.6, 150.6, 150.5, 147.2, 146.4, 146.2, 146.1, 145.5, 143.7,
143.5, 133.7, 133.6, 132.1, 131.5, 131.4, 131.3, 131.2, 130.8, 130.7,
130.5, 130.3, 129.7, 127.2, 127.0, 126.8, 126.6, 126.5, 126.3, 126.2,
125.9, 125.8, 125.4, 124.8, 123.8, 122.9, 122.1, 122.0, 121.5, 119.9,
34.7, 34.3, 34.2, 34.1, 31.7, 31.6, 31.55, 31.5, 29.4, 29.2, 28.9, 28.6,
28.1, 27.7, 27.65, 27.6, 27.5, 26.2, 26.0, 25.8, 25.4, 25.0, 23.75, 23.7,
23.6, 23.5, 23.4, 23.0, 22.8, 22.5, 22.4, 21.9, 13.8. 31P{1H} (162
MHz, CD2Cl2, 27 °C): δ 31.37 and 31.19 (2s). MS (ESI, MeOH/
CH2Cl2): m/z 995.6 [M - Cl]þ. Anal. Calcd for C60H79Cl2N2-
PRu 1.5MeOH: C, 68.44; H, 7.94; N, 2.60. Found: C, 68.11; H,
3
7.80; N, 2.74.
4.3. Time-Conversion Studies. 4.3.1. General Remarks.
All catalytic samples were prepared under an inert atmosphere
of nitrogen using gloveboxes. All reactions were run in NMR
tubes equipped with a screw-cap septum top at 300 K (27 °C) at
a 0.1 M substrate/solvent ratio, and the conversions were
1
followed by H NMR spectroscopy. Substrates 7,36 8,12 11,38
and 1239 were synthesized according to literature procedures.
4.3.2. RCM of Diallyltosylamide (7) and Diethyl Diallylma-
lonate (8). 4.3.2.1. Catalyst Loading of 1 mol %. To obtain the
required catalyst amount, a solution of the appropriate ruthe-
nium complex (4 ꢀ 10-3 mmol) in 2 mL of CH2Cl2 was pre-
pared. A 400 μL portion of this solution was transferred to a
NMR tube and evaporated to dryness, and the residue was dried
for 1 h under vacuum. The tube was then closed with a screw-cap
septum top. Separately, in a small vial, substrates 7 and 8
(0.08 mmol, 20.1 and 19.2 mg, respectively) were dissolved in
0.8 mL (0.1 M) of CD2Cl2 and then transferred via syringe to the
respective NMR tubes containing the catalyst. The tube was
vigorously stirred for a few seconds (the reaction time was
started at this point) and introduced into the spectrometer,
and conversions were obtained by 1H NMR.
(37) Terada, Y.; Mitsuhiro, M.; Nishida, A. Angew. Chem., Int. Ed.
2004, 43, 4063.
(38) Yao, Q.; Zhang, Y. J. Am. Chem. Soc. 2004, 126, 74.
(39) Kotora, M.; Tursk, M.; Nectas, D. J. Am. Chem. Soc. 2004, 126,
10222.
(40) (a) Kirkland, T. A.; Grubbs, R. H. J. Org. Chem. 1997, 62, 7310.
(b) Bien, S.; Ovadia, D. J. Chem. Soc., Perkin Trans. 1 1974, 333.
(c) Baylouny, B. A. J. Am. Chem. Soc. 1971, 93, 4621. (d) F€urstner, A.;
Guth, O.; D€uffels, A.; Seidel, G.; Liebl, M.; Gabor, B.; Mynott, R. Chem.
Eur. J. 2001, 7, 4811. (e) Garbacia, S.; Desai, B.; Lavastre, O.; Kappe, C. O.
J. Org. Chem. 2003, 68, 9136. (f) Tamaru, Y.; Hojo, M.; Yoshida, Z. J. Org.
Chem. 1988, 53, 5731. (g) Brace, N. O. J. Org. Chem. 1971, 36, 3187.
(h) Edwards, P. G.; Paisey, S. J.; Tooze, R. P. J. Chem. Soc., Perkin Trans. 1
2000, 3122. (i) Diez-Barra, E.; de la Hoz, A.; Moreno, A.; Sanchez-Verdu, P.
J. Chem. Soc., Perkin Trans. 1 1991, 2589. (j) Marco, J. A.; Carda, M.;
Rodriguez, S.; Castillo, E.; Kneeteman, M. N. Tetrahedron 2003, 59, 4085.
(k) Schmidt, B. J. Chem. Soc., Perkin Trans. 1 1999, 2627. (l) Ojima, I.; Vu,
A. T.; Lee, S.-Y.; McCullagh, J. V.; Moralee, A. C.; Fujiwara, M.; Hoang,
T. H. J. Am. Chem. Soc. 2002, 124, 9164. (m) MoCri, M.; Sakakibara, N.;
Kinoshita, A. J. Org. Chem. 1998, 63, 6082. (n) Kataoka, T.; Yoshimatsu, M.;
Noda, Y.; Sato, T.; Shimizu, H.; Hori, M. J. Chem. Soc., Perkin Trans. 1 1993,
121. (o) F€urstner, A.; Ackermann, L.; Gabor, B.; Lehmann, C. W.; Mynott, R.;
Stelzer, F.; Thiel, O. R. Chem. Eur. J. 2001, 7, 3226. (p) Clavier, H.; Nolan,
S. P.; Mauduit, M. Organometallics 2008, 27, 2287. (q) Schleicher, K. D.;
Jamison, T. F. Org. Lett. 2007, 9, 875. (r) Blackwell, H. E.; O'Leary, D. J.;
Chatterjee, A. K.; Washenfelder, R. A.; Bussmann, D. A.; Grubbs, R. H. J. Am.
Chem. Soc. 2000, 122, 58.
4.3.2.2. Catalyst Loading of 0.1 mol %. To obtain the re-
quired catalyst amount, a solution of the appropriate ruthenium
complex (8 ꢀ 10-3 mmol) in 10 mL of CH2Cl2 was prepared. A
100 μL portion of this solution was transferred to a NMR tube
and evaporated to dryness, and the residue was dried for 1 h
under vacuum. The tube was then closed with a screw-cap
septum top. Separately, in a small vial, substrates 7 and 8
(0.08 mmol, 20.1 and 19.2 mg, respectively) were dissolved in
0.8 mL (0.1 M) of CD2Cl2 and then transferred via syringe to the
respective NMR tube containing the catalyst. The tube was
vigorously stirred for a few seconds (the reaction time was